Lincoln Pharmaceuticals Ltd achieves the milestone of Rs. 533 crore Revenue and Rs. 100 crore Profit before Tax for the first time in a Financial Year for FY2022-23

Mr. Mahendra Patel, MD, Lincoln Pharmaceuticals Ltd FY23 Results Highlights:– (Standalone) ·         Net Profit Reports Y-o-Y growth of 5.11% to Rs. 72.90 crore; ·         Total Income reports Y-o-Y growth of 10.52% to Rs. 532.79 crore; ·         EBITDA reports Y-o-Y growth of 5.86% to Rs. 111.65 crore. ·         Company recommends 15% dividend, Rs. 1.5 per share for FY 23 Q4FY23 Results Highlights:– (Standalone) ·         Net Profit Reports Y-o-Y […]

Continue Reading

Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 15.01 crore in Q1FY23

Mr. Mahendra Patel, MD, Lincoln Pharmaceuticals Ltd Business Highlights:– Total Income in Q1FY23 at Rs. 129.97 crore, up 24.4% from Rs. 104.4 crore in Q4FY22 Commercial operations of Cephalosporin Plant and Export to EU & Australia to commence in FY23 Company continuous to remain ‘Net Debt Free’ after multiple expansion & acquisition of Cephalosporin plant […]

Continue Reading